3-119703163-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033364.4(CFAP91):c.65G>A(p.Arg22Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,605,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033364.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP91 | NM_033364.4 | c.65G>A | p.Arg22Gln | missense_variant | 1/18 | ENST00000273390.9 | NP_203528.3 | |
CFAP91 | NM_001320316.2 | c.-45G>A | 5_prime_UTR_variant | 1/18 | NP_001307245.2 | |||
CFAP91 | NM_001320317.2 | c.-45G>A | 5_prime_UTR_variant | 1/17 | NP_001307246.2 | |||
CFAP91 | NM_001320318.2 | c.-79G>A | 5_prime_UTR_variant | 1/16 | NP_001307247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP91 | ENST00000273390.9 | c.65G>A | p.Arg22Gln | missense_variant | 1/18 | 1 | NM_033364.4 | ENSP00000273390.5 | ||
ENSG00000285585 | ENST00000648112.1 | c.65G>A | p.Arg22Gln | missense_variant | 1/18 | ENSP00000497876.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000257 AC: 6AN: 233228Hom.: 0 AF XY: 0.0000317 AC XY: 4AN XY: 126320
GnomAD4 exome AF: 0.0000131 AC: 19AN: 1453186Hom.: 0 Cov.: 32 AF XY: 0.0000152 AC XY: 11AN XY: 721976
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2022 | The c.65G>A (p.R22Q) alteration is located in exon 1 (coding exon 1) of the MAATS1 gene. This alteration results from a G to A substitution at nucleotide position 65, causing the arginine (R) at amino acid position 22 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at